Skip to main content

Advertisement

Log in

Persistent use of false myeloma cell lines

  • Review
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

Multiple myeloma (MM) is a neoplasm of a terminally differentiated B-cell. Human myeloma cell lines were shown to be suitable model systems for use in various fields of the biological sciences. Within the last 20 years more than 100 cell lines have been established. So-called ‘mdeloma cell lines’ have been previously reported and are still widely used which are in reality Epstein-Barr virus (EBV-positive Blymphoblastoid cell lines. The presence of the EBV-genome in residual normal B-cells provides them with a selective growth advantage after explantation. Cell lines represent an extremely important resource for research in a variety of fields and disciplines. AS the cell lines are used as in vitro model systems in lieu of primary material, it is crucial that the cells in the culture flasks faithfully correspond to the purported objects of study. On closer examination, the use of false cell lines may be seen to invalidate a significant percentage of scientific work, or at least cast doubts on the relevance of these in vitro results to the cell type or tumor in vivo. Ultimately, use of cross-contaminated cell lines is a waste of human and material resources. Henceforth, it should be mandatory to prove the proper derivation of each new cell line by comparing DNA fingerprints or karyotypes of the patient’s primary cells and the cultured cells. The availability of well characterized and authenticated bona fide MM cell lines is of great importance for the study of the biology, etiology and treatment of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MacLeod RAF, Dirks WG, Drexler HG Persistent use of misidentified cell lines and its prevention. Genes Chromosomes Cancer 33: 103–105, 2002.

    Article  PubMed  Google Scholar 

  2. Masters JRW Human cancer cell lines: Fact and fantasy. Nature Reviews (Mol Cell Biol) 1: 233–236, 2000.

    Article  CAS  Google Scholar 

  3. Stacey GN, Masters JRW, Hay RJ, et al.: Cell contamination leads to inaccurate data: We must take action now. Nature 403: 356, 2000.

    Article  PubMed  CAS  Google Scholar 

  4. Lavappa KS Survey of ATCC stocks of human cell lines for HeLa contamination. In Vitro 14: 469–475, 1978.

    Article  PubMed  CAS  Google Scholar 

  5. Drexler HG, Dirks WG, MacLeod RAF: False human hematopoietic cell lines: Cross-contaminations and misinterpretations. Leukemia 13: 1601–1607, 1999.

    Article  PubMed  CAS  Google Scholar 

  6. MacLeod RA, Dirks WG, Matsuo Y, et al.: Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83: 555–563, 1999.

    Article  PubMed  CAS  Google Scholar 

  7. Matsuoka Y, Moore GE, Yagi Y, et al.: Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 125: 1246–1250, 1967.

    PubMed  CAS  Google Scholar 

  8. Drexler HG, Minowada J: History and classification of human leukemia-lymphoma cell lines. Leukemia Lymphoma 31: 305–316, 1998.

    PubMed  CAS  Google Scholar 

  9. Nilsson K, Pontén J: Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15: 321–341, 1975.

    Article  PubMed  CAS  Google Scholar 

  10. Pellat-Deceunynk C, Amiot M, Bataille R, et al.: Human myeloma cell lines as a tool for studying the biology of multiple myeloma: A reappraisal 18 years after. Blood 86: 4001–4002, 1985.

    Google Scholar 

  11. Drexler HG, Matsuo Y: Malignant hematopoietic cell lines: In vitro models for the study of multiple myeloma and plasma cell leukemia. Leukemia Res 24: 681–703, 2000.

    Article  CAS  Google Scholar 

  12. Drexler HG (ed): The Leukemia-Lymphoma Cell Line FactsBook. Academic Press, London, 2000.

    Google Scholar 

  13. DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen. http://www.dsmz.de.

  14. ATCC-American Type Culture Collection. http://www.atcc.org.

  15. Drexler HG, MacLeod RAF, Dirks WG: Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell line. Blood 98: 3495–3496, 2001.

    Article  PubMed  CAS  Google Scholar 

  16. Underhill GH, George D, Bremer EG, et al.: Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 101: 4013–4021, 2003.

    Article  PubMed  CAS  Google Scholar 

  17. Klein U, Gloghini A, Gaidano G, et al.: Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101: 4115–4121, 2003.

    Article  PubMed  CAS  Google Scholar 

  18. JCRB-Japanese Collection of Research Bioresources. http://cellbank.nihs.go.jp

  19. Drexler HG, Dirks WG, Matsuo Y, et al.: False leukemia-lymphoma cell lines: An update on over 500 cell lines. Leukemia 17: 416–426, 2003.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans G. Drexler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drexler, H.G., Matsuo, Y. & Macleod, R.A.F. Persistent use of false myeloma cell lines. Hum Cell 16, 101–105 (2003). https://doi.org/10.1111/j.1749-0774.2003.tb00140.x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1749-0774.2003.tb00140.x

Keywords

Navigation